“Targeted Nanostructured Lipid Carrier-Mediated Flavonoid Delivery for Enhanced Therapeutic Efficacy in Non-Small Cell Lung Cancer (NSCLC)”, APIMR, vol. 1, no. 1, pp. 73–97, Jun. 2026, Accessed: Jul. 16, 2026. [Online]. Available: https://apimr.nknpub.com/1/article/view/4